Group One Trading’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.7K | Sell |
7,600
-9,800
| -56% | -$82K | ﹤0.01% | 5203 |
|
|
2026
Q1 | $144K | Buy |
17,400
+700
| +4% | +$7.25K | ﹤0.01% | 4396 |
|
|
2025
Q4 | $206K | Buy |
16,700
+10,000
| +149% | +$107K | ﹤0.01% | 4345 |
|
|
2025
Q3 | $59.1K | Sell |
6,700
-10,800
| -62% | -$84K | ﹤0.01% | 5810 |
|
|
2025
Q2 | $112K | Sell |
17,500
-7,600
| -30% | -$43.5K | ﹤0.01% | 4878 |
|
|
2025
Q1 | $122K | Buy |
25,100
+18,100
| +259% | +$150K | ﹤0.01% | 4440 |
|
|
2024
Q4 | $66.9K | Sell |
7,000
-23,800
| -77% | -$218K | ﹤0.01% | 4836 |
|
|
2024
Q3 | $257K | Sell |
30,800
-48,200
| -61% | -$438K | ﹤0.01% | 3398 |
|
|
2024
Q2 | $539K | Sell |
79,000
-20,600
| -21% | -$88.6K | ﹤0.01% | 2495 |
|
|
2024
Q1 | $252K | Sell |
99,600
-7,200
| -7% | -$16.2K | ﹤0.01% | 3355 |
|
|
2023
Q4 | $256K | Buy |
106,800
+52,400
| +96% | +$123K | ﹤0.01% | 3644 |
|
|
2023
Q3 | $185K | Buy |
54,400
+39,000
| +253% | +$216K | ﹤0.01% | 3871 |
|
|
2023
Q2 | $113K | Sell |
15,400
-3,000
| -16% | -$27.8K | ﹤0.01% | 4492 |
|
|
2023
Q1 | $191K | Buy |
18,400
+7,700
| +72% | +$93.1K | ﹤0.01% | 3727 |
|
|
2022
Q4 | $126K | Sell |
10,700
-8,500
| -44% | -$132K | ﹤0.01% | 4226 |
|
|
2022
Q3 | $403K | Buy |
19,200
+11,000
| +134% | +$306K | ﹤0.01% | 3446 |
|
|
2022
Q2 | $255K | Sell |
8,200
-1,500
| -15% | -$51.2K | ﹤0.01% | 4063 |
|
|
2022
Q1 | $398K | Sell |
9,700
-2,200
| -18% | -$97K | ﹤0.01% | 4062 |
|
|
2021
Q4 | $517K | Sell |
11,900
-6,400
| -35% | -$290K | ﹤0.01% | 4099 |
|
|
2021
Q3 | $916K | Sell |
18,300
-18,900
| -51% | -$1.14M | ﹤0.01% | 3512 |
|
|
2021
Q2 | $2.34M | Buy |
37,200
+31,400
| +541% | +$2.02M | ﹤0.01% | 2470 |
|
|
2021
Q1 | $539K | Sell |
5,800
-4,200
| -42% | -$430K | ﹤0.01% | 3952 |
|
|
2020
Q4 | $896K | Sell |
10,000
-2,500
| -20% | -$229K | ﹤0.01% | 2747 |
|
|
2020
Q3 | $1.29M | Buy |
+12,500
| New | +$1.35M | ﹤0.01% | 1962 |
|
|
2017
Q3 | – | Sell |
-9,000
| Closed | -$305K | – | 4897 |
|
|
2017
Q2 | $305K | Buy |
+9,000
| New | +$278K | ﹤0.01% | 2333 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$7K | – | 4710 |
|
|
2016
Q4 | $7K | Buy |
+200
| New | +$6K | ﹤0.01% | 4025 |
|
|
2016
Q3 | – | Sell |
-5,000
| Closed | -$141K | – | 4612 |
|
|
2016
Q2 | $141K | Buy |
+5,000
| New | +$196K | ﹤0.01% | 2637 |
|
Other funds holding EBS
OHA
Group One Trading's EBS Position: Q2 2026 in Review
Group One Trading sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 18,149 shares — an estimated $152K sold.
Group One Trading first reported a position in EBS in Q2 2016 and held it in 25 quarters. The position peaked at $2.84M in Q3 2020. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Group One Trading reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 18,149 Emergent Biosolutions shares in Q2 2026, an estimated $152K.
- Group One Trading first reported a position in Emergent Biosolutions in Q2 2016 and held it in 25 quarters.
- Group One Trading's Emergent Biosolutions position peaked at $2.84M in Q3 2020.
- 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.